Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01016899 · ClinicalTrials.gov registry record
Electronic Brachytherapy for the Treatment of NMSC
A clinical trial of Squamous Cell Carcinoma and Basal Cell Carcinoma, sponsored by Xoft.
- Completed
- Registry status
- 187
- Enrollment target
- 5
- Study locations
NCT01016899: Completed study of Squamous Cell Carcinoma and Basal Cell Carcinoma, sponsored by Xoft.
NCT01016899 is a study of Squamous Cell Carcinoma and Basal Cell Carcinoma that has completed, run by Xoft. The registered enrollment target is 187 participants, above the 100-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (87% higher). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01016899, a study of Squamous Cell Carcinoma and Basal Cell Carcinoma, has completed, sponsored by Xoft.
- COMPLETED
- Registry status
- 187 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective of this study is to record recurrence in patients treated for nonmelanoma (basal cell and squamous cell carcinomas) skin cancer using the Xoft Axxent Electronic Brachytherapy System. Additional objectives include evaluate the appearance of the treated area in patients treated for nonmelanoma skin cancer using the Xoft Axxent Electronic Brachytherapy System and record the occurrence of radiation therapy related skin changes in patients treated for nonmelanoma skin cancer.
Primary Outcome
Local recurrence
Conditions Studied
Interventions
- RADIATION electronic brachytherapy
Study Locations (5)
Arizona
- Cancer Treatment Services - AZ - Casa Grande
- Southwest Oncology Centers - Scottsdale
Alabama
- DCH Cancer Center - Tuscaloosa
California
- Diablo Valley Oncology and Hematology Medical Group - Pleasant Hill
Tennessee
- Parkridge Medical Center - Sara Cannon Cancer Center - Chattanooga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2009-08 |
| Est. Completion | 2013-08 |
What the finished NCT01016899 record still lists
NCT01016899 is an observational study that tracks outcomes without assigning an intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap, above the 100-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (87% higher).
The record links to 2 conditions, with Squamous Cell Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which electronic brachytherapy is the first listed.
NCT01016899 lists 5 locations in 4 states (Arizona, Alabama, California).
Frequently Asked Questions
What is clinical trial NCT01016899 about?
NCT01016899 is a clinical study titled "Electronic Brachytherapy for the Treatment of NMSC". The objective of this study is to record recurrence in patients treated for nonmelanoma (basal cell and squamous cell carcinomas) skin cancer using the Xoft Axxent Electronic Brachytherapy System. Additional objectives include evaluate the appearance of the treated area in patients treated for nonme...
What is the current status of trial NCT01016899?
This trial is currently completed. The enrollment target is 187 participants. The study started on 2009-08. Estimated completion is 2013-08.
What conditions does trial NCT01016899 study?
This clinical trial studies the following conditions: Squamous Cell Carcinoma, Basal Cell Carcinoma.
What interventions are being tested in trial NCT01016899?
The interventions under investigation include: electronic brachytherapy (RADIATION).
Who is sponsoring clinical trial NCT01016899?
This trial is sponsored by Xoft, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01016899 being conducted?
This trial has 5 study locations across Alabama, Arizona, California, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Squamous Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01016899's enrollment target sits among peer trials
187 6th of 47 higher than 42 of 47 other Squamous Cell Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Squamous Cell Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
RECRUITING · Phase 2
-
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
RECRUITING · NA
-
Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin
RECRUITING · Phase 2
-
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
RECRUITING · Phase 1
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Toripalimab With Chemotherapy for Sinus Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06153251 · 187 participants · Phase 1
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06254898 · 187 participants · NA
Use of Incentives for Stressful Medical Procedures
- NCT07062237 · 187 participants · NA
A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence
- NCT07217574 · 187 participants
Program in Oncology for Tribal Health Systems.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia